Page last updated: 2024-10-26

valproic acid and Hepatitis

valproic acid has been researched along with Hepatitis in 2 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Hepatitis: INFLAMMATION of the LIVER.

Research Excerpts

ExcerptRelevanceReference
" He had been obese, had been receiving a standard dose of valproic acid since clipping surgery for subarachnoid hemorrhage 17 years previously, and had not consumed any alcohol since the surgery."7.73Hepatocellular carcinoma and nonalcoholic steatohepatitis developing during long-term administration of valproic acid. ( Iizuka, H; Katsuda, S; Okamoto, K; Sato, K; Ueda, Y; Ueno, K, 2005)
" He had been obese, had been receiving a standard dose of valproic acid since clipping surgery for subarachnoid hemorrhage 17 years previously, and had not consumed any alcohol since the surgery."3.73Hepatocellular carcinoma and nonalcoholic steatohepatitis developing during long-term administration of valproic acid. ( Iizuka, H; Katsuda, S; Okamoto, K; Sato, K; Ueda, Y; Ueno, K, 2005)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sato, K1
Ueda, Y1
Ueno, K1
Okamoto, K1
Iizuka, H1
Katsuda, S1
Klotz, U1
Rapp, T1
Müller, WA1

Other Studies

2 other studies available for valproic acid and Hepatitis

ArticleYear
Hepatocellular carcinoma and nonalcoholic steatohepatitis developing during long-term administration of valproic acid.
    Virchows Archiv : an international journal of pathology, 2005, Volume: 447, Issue:6

    Topics: Anticonvulsants; Carcinoma, Hepatocellular; Fatty Liver; Hepatitis; Humans; Liver Neoplasms; Male; M

2005
Disposition of valproic acid in patients with liver disease.
    European journal of clinical pharmacology, 1978, Mar-17, Volume: 13, Issue:1

    Topics: Adult; Biological Availability; Half-Life; Hepatitis; Humans; Kinetics; Liver Cirrhosis, Alcoholic;

1978